ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
8
views
0
references
Top references
cited by
67
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
4,087
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Development of antiretroviral drug resistance.
Author(s):
M Wainberg
,
Gerasimos J Zaharatos
,
Michael B Brenner
Publication date:
2011-08-18
Journal:
The New England journal of medicine
Keywords:
Anti-Retroviral Agents
,
pharmacology
,
therapeutic use
,
Drug Resistance, Viral
,
genetics
,
Drug Therapy, Combination
,
HIV Infections
,
drug therapy
,
HIV Integrase Inhibitors
,
HIV Protease Inhibitors
,
HIV-1
,
drug effects
,
Humans
,
Mutation
,
Reverse Transcriptase Inhibitors
Read this article at
ScienceOpen
Publisher
PubMed
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Drug_transporters
Author and article information
Journal
PubMed ID::
21848464
DOI::
10.1056/NEJMra1004180
ScienceOpen disciplines:
Chemistry
Keywords:
Anti-Retroviral Agents
,
pharmacology
,
therapeutic use
,
Drug Resistance, Viral
,
genetics
,
Drug Therapy, Combination
,
HIV Infections
,
drug therapy
,
HIV Integrase Inhibitors
,
HIV Protease Inhibitors
,
HIV-1
,
drug effects
,
Humans
,
Mutation
,
Reverse Transcriptase Inhibitors
Data availability:
ScienceOpen disciplines:
Chemistry
Keywords:
Anti-Retroviral Agents
,
pharmacology
,
therapeutic use
,
Drug Resistance, Viral
,
genetics
,
Drug Therapy, Combination
,
HIV Infections
,
drug therapy
,
HIV Integrase Inhibitors
,
HIV Protease Inhibitors
,
HIV-1
,
drug effects
,
Humans
,
Mutation
,
Reverse Transcriptase Inhibitors
Comments
Comment on this article
Sign in to comment
scite_
Similar content
4,087
HIV encephalitis in a patient on antiretroviral therapy: a case report.
Authors:
Maria Hlebowicz
,
Miłosz Parczewski
,
Paweł Jakubowski
The relationship between AIDS retinal cotton wool spots and neuropsychological impairment in HIV-positive individuals in the pre-highly active antiretroviral therapy era.
Authors:
William R. Freeman
,
J. McCutchan
,
J. Arevalo
…
Immune reconstitution in HIV-1 infected patients treated for two years with highly active antiretroviral therapy
Authors:
R. Almeida
,
L. Souza
,
S. A. Calvi
…
See all similar
Cited by
66
The CRISPR/Cas9 system inactivates latent HIV-1 proviral DNA
Authors:
Weijun Zhu
,
Rongyue Lei
,
Yann Le Duff
…
Selective resistance profiles emerging in patient-derived clinical isolates with cabotegravir, bictegravir, dolutegravir, and elvitegravir
Authors:
Maureen Oliveira
,
Ruxandra-Ilinca Ibanescu
,
Kaitlin Anstett
…
Low-Cost Ultra-Wide Genotyping Using Roche/454 Pyrosequencing for Surveillance of HIV Drug Resistance
Authors:
Dawn Dudley
,
Emily N Chin
,
Benjamin Bimber
…
See all cited by